PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript March 27, 2025
PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29.
Operator: Good morning. And welcome to PDS Biotech’s Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] At this time, I would now like to turn the conference over to Tom Johnson of LifeSci Advisors. Please go ahead, sir.
Tom Johnson: Thank you, operator. Good...
